PF-07263689

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07263689, covering 2024-04-12 to 2024-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]